Advertisement
Screener

SERA PROGNOSTICS, INC. (SERA) Increase (Decrease) in Contract with Customer, Liability

SERA PROGNOSTICS, INC. Increase (Decrease) in Contract with Customer, Liability

SERA PROGNOSTICS, INC. (SERA) reported Increase (Decrease) in Contract with Customer, Liability of -$19.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-12

  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$14.00K.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$5.00K.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$4.00K.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $99.00K.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2025 was $92.00K.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2024 was -$12.00K, a 100.11% decline from fiscal 2023.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was $11.15M, a 86.96% increase from fiscal 2022.
  • SERA PROGNOSTICS, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was $5.97M, a 91.46% increase from fiscal 2021.
Period endIncrease (Decrease) in Contract with Customer, Liability 3 monthIncrease (Decrease) in Contract with Customer, Liability 6 monthIncrease (Decrease) in Contract with Customer, Liability 9 monthIncrease (Decrease) in Contract with Customer, Liability 12 month
2026-06-30-$14.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
-$19.00K
10-Q · filed 2026-08-12
-$23.00K
derived: sum of 3 quarters · filed 2026-08-12
$76.00K
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31-$5.00K
10-Q · filed 2026-05-06
-$9.00K
derived: sum of 2 quarters · filed 2026-05-06
$90.00K
derived: sum of 3 quarters · filed 2026-05-06
$89.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31-$4.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$95.00K
derived: sum of 2 quarters · filed 2026-03-18
$94.00K
derived: sum of 3 quarters · filed 2026-08-12
$92.00K
10-K · filed 2026-03-18
2025-09-30$99.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$98.00K
derived: sum of 2 quarters · filed 2026-08-12
$96.00K
10-Q · filed 2025-11-13
$93.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30-$1.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12
-$3.00K
10-Q · filed 2026-08-12
-$6.00K
derived: sum of 3 quarters · filed 2026-08-12
-$8.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31-$2.00K
10-Q · filed 2026-05-06
-$5.00K
derived: sum of 2 quarters · filed 2026-05-06
-$7.00K
derived: sum of 3 quarters · filed 2026-05-06
-$9.00K
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$3.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
-$5.00K
derived: sum of 2 quarters · filed 2026-03-18
-$7.00K
derived: sum of 3 quarters · filed 2026-03-18
-$12.00K
10-K · filed 2026-03-18
2024-09-30-$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
-$4.00K
derived: sum of 2 quarters · filed 2025-11-13
-$9.00K
10-Q · filed 2025-11-13
$11.19M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$2.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06
-$7.00K
10-Q · filed 2025-08-06
$11.19M
derived: sum of 3 quarters · filed 2025-08-06
$11.18M
derived: sum of 4 quarters · filed 2025-08-06
2024-03-31-$5.00K
10-Q · filed 2025-05-07
$11.19M
derived: sum of 2 quarters · filed 2025-05-07
$11.18M
derived: sum of 3 quarters · filed 2025-05-07
$11.16M
derived: sum of 4 quarters · filed 2025-05-07
2023-12-31$11.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-19
$11.19M
derived: sum of 2 quarters · filed 2025-03-19
$11.17M
derived: sum of 3 quarters · filed 2025-03-19
$11.15M
10-K · filed 2025-03-19
2023-09-30-$10.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06
-$28.00K
derived: sum of 2 quarters · filed 2024-11-06
-$42.00K
10-Q · filed 2024-11-06
$5.95M
derived: sum of 4 quarters · filed 2024-11-06
2023-06-30-$18.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$32.00K
10-Q · filed 2024-08-07
$5.96M
derived: sum of 3 quarters · filed 2024-08-07
$5.95M
derived: sum of 4 quarters · filed 2024-08-07
2023-03-31-$14.00K
10-Q · filed 2024-05-08
$5.98M
derived: sum of 2 quarters · filed 2024-05-08
$5.97M
derived: sum of 3 quarters · filed 2024-05-08
$5.96M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31$5.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20
$5.98M
derived: sum of 2 quarters · filed 2024-03-20
$5.97M
derived: sum of 3 quarters · filed 2024-03-20
$5.97M
10-K · filed 2024-03-20
2022-09-30-$11.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
-$21.00K
derived: sum of 2 quarters · filed 2023-11-08
-$25.00K
10-Q · filed 2023-11-08
$3.09M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30-$10.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$14.00K
10-Q · filed 2023-08-09
$3.10M
derived: sum of 3 quarters · filed 2023-08-09
$3.10M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31-$4.00K
10-Q · filed 2023-05-10
$3.11M
derived: sum of 2 quarters · filed 2023-05-10
$3.11M
derived: sum of 3 quarters · filed 2023-05-10
$3.11M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$3.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22
$3.12M
derived: sum of 2 quarters · filed 2023-03-22
$3.12M
derived: sum of 3 quarters · filed 2023-03-22
$3.12M
10-K · filed 2023-03-22
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$0.00
derived: sum of 2 quarters · filed 2022-11-09
$0.00
10-Q · filed 2022-11-09
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10
$0.00
10-Q · filed 2022-08-10
2021-03-31$0.00
10-Q · filed 2022-05-10
2020-12-31$0.00
10-K · filed 2022-03-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
Freenome, Inc. (FRNM)United States$0.143B
EXAGEN INC. (XGN)United States$0.212B-5.95
BIODESIX INC (BDSX)United States$0.312B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45